Back

Rate lowering and anti-arrhythmic drugs as monotherapy or dual therapy on the risk of pacemaker implantation in patients with atrial fibrillation

18 March 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Young EP Poster Session - Young meets Experienced Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Frederik Dalgaard

Gentofte University Hospital, Gentofte (Denmark)

16 More presentations in this session

Presentation thumbnail
Poster discussant
Presentation thumbnail
Incidence of pulmonary vein conduction recovery after a 2-minute cryoballoon freeze for pulmonary vein isolation
Doctor A. Pott (Lingen, DE)
Abstract
Presentation thumbnail
Role of the late sodium current in determining electrophysiological characteristics of cardiac ventricular myocytes
Doctor B. Horvath (Debrecen, HU)
Abstract Slides
Presentation thumbnail
Validation of a novel computer model of endo-epicardial electrical dissociation and transmural conduction during atrial fibrillation
Doctor A. Gharaviri (Lugano, CH)
Abstract
Presentation thumbnail
Augmented contractile remodeling is associated with increased susceptibility to drug-induced torsade de pointes arrhythmias in the chronic AV-block dog model
Mr D. Sprenkeler (Utrecht, NL)
Abstract

Access the full session

Session thumbnail
Young EP Poster Session - Young meets Experienced

The Event

Event poster

EHRA 2018

18 March 2018 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources